Intellia Therapeutics, Inc. (NTLA)
12.46
-0.77
(-5.82%)
USD |
NASDAQ |
Oct 30, 16:00
12.39
-0.07
(-0.56%)
After-Hours: 20:00
Intellia Therapeutics Cash and Short Term Investments (Annual) : 449.88M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 449.88M |
| December 31, 2024 | 601.52M |
| December 31, 2023 | 912.22M |
| December 31, 2022 | 1.193B |
| December 31, 2021 | 748.69M |
| December 31, 2020 | 600.07M |
| Date | Value |
|---|---|
| December 31, 2019 | 279.73M |
| December 31, 2018 | 314.06M |
| December 31, 2017 | 340.68M |
| December 31, 2016 | 273.06M |
| December 31, 2015 | 75.82M |
| December 31, 2014 | 9.845M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Twist Bioscience Corp. | 232.43M |
| Beam Therapeutics, Inc. | 1.245B |
| Prime Medicine, Inc. | 177.68M |
| 10X Genomics, Inc. | 523.41M |
| Moderna, Inc. | 5.80B |